2017 Q3 Form 10-Q Financial Statement
#000164033417002388 Filed on November 14, 2017
Income Statement
| Concept | 2017 Q3 | 2016 Q3 |
|---|---|---|
| Revenue | $934.00 | $402.00 |
| YoY Change | 132.34% | 4.15% |
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | $402.00 | |
| YoY Change | 4.15% | |
| Gross Profit Margin | 100.0% | |
| Selling, General & Admin | $160.0K | $30.00K |
| YoY Change | 433.33% | 376.8% |
| % of Gross Profit | 7462.69% | |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $10.81K | $11.09K |
| YoY Change | -2.57% | -28.96% |
| % of Gross Profit | 2759.45% | |
| Operating Expenses | $172.9K | $42.04K |
| YoY Change | 311.18% | -95.33% |
| Operating Profit | -$171.9K | -$41.64K |
| YoY Change | 312.91% | -95.37% |
| Interest Expense | $100.5K | $0.00 |
| YoY Change | -100.0% | |
| % of Operating Profit | ||
| Other Income/Expense, Net | -$234.7K | -$2.178K |
| YoY Change | 10675.62% | -99.44% |
| Pretax Income | -$410.0K | -$40.00K |
| YoY Change | 925.0% | -96.9% |
| Income Tax | ||
| % Of Pretax Income | ||
| Net Earnings | -$406.6K | -$43.82K |
| YoY Change | 827.98% | -96.6% |
| Net Earnings / Revenue | -43536.72% | -10900.25% |
| Basic Earnings Per Share | ||
| Diluted Earnings Per Share | -$0.12 | -$0.02 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 464.7M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2017 Q3 | 2016 Q3 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $0.00 | $10.00K |
| YoY Change | -100.0% | -80.0% |
| Cash & Equivalents | $548.00 | $5.340K |
| Short-Term Investments | ||
| Other Short-Term Assets | $0.00 | |
| YoY Change | -100.0% | |
| Inventory | ||
| Prepaid Expenses | $4.667K | |
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $548.00 | $10.01K |
| YoY Change | -94.52% | -99.02% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $28.24K | $71.55K |
| YoY Change | -60.54% | 17.38% |
| Goodwill | ||
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $28.24K | $71.55K |
| YoY Change | -60.54% | 17.38% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $548.00 | $10.01K |
| Total Long-Term Assets | $28.24K | $71.55K |
| Total Assets | $28.78K | $81.56K |
| YoY Change | -64.71% | -92.47% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $100.0K | $2.394K |
| YoY Change | 4077.11% | 299.0% |
| Accrued Expenses | $150.0K | $60.00K |
| YoY Change | 150.0% | -86.36% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $140.0K | $0.00 |
| YoY Change | -100.0% | |
| Total Short-Term Liabilities | $644.0K | $62.48K |
| YoY Change | 930.72% | -88.09% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $0.00 | $0.00 |
| YoY Change | ||
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $644.0K | $62.48K |
| Total Long-Term Liabilities | $0.00 | $0.00 |
| Total Liabilities | $644.0K | $62.48K |
| YoY Change | 930.72% | -88.09% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$5.189M | -$4.126M |
| YoY Change | 25.76% | 69.84% |
| Common Stock | $72.51K | $46.47K |
| YoY Change | 56.05% | 933.73% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$615.2K | $19.08K |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $28.78K | $81.56K |
| YoY Change | -64.71% | -92.47% |
Cashflow Statement
| Concept | 2017 Q3 | 2016 Q3 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$406.6K | -$43.82K |
| YoY Change | 827.98% | -96.6% |
| Depreciation, Depletion And Amortization | $10.81K | $11.09K |
| YoY Change | -2.57% | -28.96% |
| Cash From Operating Activities | -$43.87K | -$10.00K |
| YoY Change | 338.69% | -50.0% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | ||
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $0.00 | |
| YoY Change | ||
| Cash From Investing Activities | $0.00 | |
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $200.00 | |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $1.850K | 0.000 |
| YoY Change | -100.0% | |
| NET CHANGE | ||
| Cash From Operating Activities | -$43.87K | -10.00K |
| Cash From Investing Activities | 0.000 | |
| Cash From Financing Activities | $1.850K | 0.000 |
| Net Change In Cash | -$42.02K | -10.00K |
| YoY Change | 320.19% | -120.0% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$43.87K | -$10.00K |
| Capital Expenditures | ||
| Free Cash Flow | ||
| YoY Change |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q3 | dei |
Entity Registrant Name
EntityRegistrantName
|
APPYEA, INC | |
| CY2017Q3 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001568969 | |
| CY2017Q3 | dei |
Trading Symbol
TradingSymbol
|
apyp | |
| CY2017Q3 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | |
| CY2017Q3 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2017Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
887154334 | shares |
| CY2017Q3 | dei |
Document Type
DocumentType
|
10-Q | |
| CY2017Q3 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-09-30 | |
| CY2017Q3 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2017Q3 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2018 | |
| CY2017Q3 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
| CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
42567 | usd |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
548 | usd |
| CY2016Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
14637 | usd |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
5340 | usd |
| CY2017Q2 | us-gaap |
Assets Current
AssetsCurrent
|
42567 | usd |
| CY2017Q3 | us-gaap |
Assets Current
AssetsCurrent
|
548 | usd |
| CY2017Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
39044 | usd |
| CY2017Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
28236 | usd |
| CY2017Q2 | us-gaap |
Assets
Assets
|
81611 | usd |
| CY2017Q3 | us-gaap |
Assets
Assets
|
28784 | usd |
| CY2017Q2 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
128000 | usd |
| CY2017Q3 | us-gaap |
Accrued Salaries Current
AccruedSalariesCurrent
|
152000 | usd |
| CY2017Q2 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
174904 | usd |
| CY2017Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
174904 | usd |
| CY2017Q3 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
138576 | usd |
| CY2017Q3 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
138576 | usd |
| CY2017Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
73608 | usd |
| CY2017Q3 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
75258 | usd |
| CY2017Q2 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
114316 | usd |
| CY2017Q3 | us-gaap |
Derivative Liabilities Current
DerivativeLiabilitiesCurrent
|
178883 | usd |
| CY2017Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
496821 | usd |
| CY2017Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
643973 | usd |
| CY2017Q2 | us-gaap |
Liabilities
Liabilities
|
496821 | usd |
| CY2017Q3 | us-gaap |
Liabilities
Liabilities
|
643973 | usd |
| CY2017Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
500 | usd |
| CY2017Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
500 | usd |
| CY2017Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
51997 | usd |
| CY2017Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
72510 | usd |
| CY2017Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4210156 | usd |
| CY2017Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4453570 | usd |
| CY2017Q2 | apyp |
Stock Payable Common Shares Value
StockPayableCommonSharesValue
|
105000 | usd |
| CY2017Q3 | apyp |
Stock Payable Common Shares Value
StockPayableCommonSharesValue
|
47727 | usd |
| CY2017Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-4782863 | usd |
| CY2017Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-5189496 | usd |
| CY2017Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-415210 | usd |
| CY2017Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-615189 | usd |
| CY2017Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
81611 | usd |
| CY2017Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
28784 | usd |
| CY2017Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
218826 | usd |
| CY2017Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
229634 | usd |
| CY2017Q2 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
87240 | usd |
| CY2017Q3 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
72927 | usd |
| CY2017Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2017Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
5000000 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
5000000 | shares |
| CY2017Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
5000000 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
5000000 | shares |
| CY2017Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2017Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
| CY2017Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1500000000 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1500000000 | shares |
| CY2017Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
519973313 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
725104637 | shares |
| CY2017Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
519973313 | shares |
| CY2017Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
725104637 | shares |
| CY2017Q3 | apyp |
Stock Payable Common Shares Shares
StockPayableCommonSharesShares
|
25000000 | shares |
| CY2016Q3 | us-gaap |
Revenues
Revenues
|
402 | usd |
| CY2017Q3 | us-gaap |
Revenues
Revenues
|
934 | usd |
| CY2016Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
2997 | usd |
| CY2017Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
64830 | usd |
| CY2016Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
27953 | usd |
| CY2017Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
97236 | usd |
| CY2016Q3 | us-gaap |
Depreciation
Depreciation
|
11093 | usd |
| CY2017Q3 | us-gaap |
Depreciation
Depreciation
|
10808 | usd |
| CY2016Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
42043 | usd |
| CY2017Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
172874 | usd |
| CY2016Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-41641 | usd |
| CY2017Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-171940 | usd |
| CY2016Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-2178 | usd |
| CY2017Q3 | us-gaap |
Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
|
-134237 | usd |
| CY2017Q3 | us-gaap |
Interest Expense
InterestExpense
|
100456 | usd |
| CY2016Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-2178 | usd |
| CY2017Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-234693 | usd |
| CY2016Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-43819 | usd |
| CY2017Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-406633 | usd |
| CY2016Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
| CY2017Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.00 | |
| CY2016Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
464667527 | shares |
| CY2017Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
664499399 | shares |
| CY2017Q3 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
81813 | usd |
| CY2016Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
2249 | usd |
| CY2017Q3 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-93263 | usd |
| CY2016Q3 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
500 | usd |
| CY2016Q3 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
24000 | usd |
| CY2017Q3 | us-gaap |
Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
|
24000 | usd |
| CY2017Q3 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
18643 | usd |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-9297 | usd |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-43869 | usd |
| CY2016Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
0 | usd |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
0 | usd |
| CY2017Q3 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
1750 | usd |
| CY2017Q3 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
100 | usd |
| CY2017Q3 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
1850 | usd |
| CY2016Q3 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-9297 | usd |
| CY2017Q3 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-42019 | usd |
| CY2016Q3 | us-gaap |
Interest Paid
InterestPaid
|
0 | usd |
| CY2017Q3 | us-gaap |
Interest Paid
InterestPaid
|
0 | usd |
| CY2016Q3 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
| CY2017Q3 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | usd |
| CY2017Q3 | apyp |
Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
|
69284 | usd |
| CY2017Q3 | us-gaap |
Notes Reduction
NotesReduction
|
137170 | usd |
| CY2017Q3 | apyp |
Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
|
67500 | usd |
| CY2017Q3 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>1. NATURE OF OPERATIONS</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company incorporated a wholly-owned subsidiary, "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">On June 9, 2017, the Company entered into a Management Services Agreement (“MSA”) with The Diagnostic Group, LLC, A Delaware limited liability company (“TDG”) under the terms of which, the Company shall perform activities related to direct marketing of TDG products and services to healthcare providers. The initial term of the Agreement will be for thirty-six (36) months from the effective date. The MSA shall automatically renew for successive one (1) year terms, unless either Party gives the other Party ninety (90) days’ written notice of termination prior to the effective date of any renewal term, or unless the MSA is terminated earlier in accordance with Section 6 of the MSA. The Company will be paid for providing services to directly recruited customers at the rate of 35% of the Net Collected Revenue collected from non-federally funded payors by third party providers affiliated or contracted with TDG for ancillary services ordered by recruited customers less any lab specific costs related to any referred samples and/or services and less any refunds or chargebacks. The Company will be paid by the 15th of each month for Net Collected Revenue from the previous month.</p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company's common stock is traded on the OTC Markets (www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</p> | |
| CY2017Q3 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Use of Estimates</b></p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"> </p> <p align="justify" style="text-align: justify; widows: 2; text-transform: none; font-style: normal; text-indent: 0px; margin: 0px; font-family: 'times new roman'; white-space: normal; orphans: 2; letter-spacing: normal; color: #000000; font-size: 13px; font-weight: normal; word-spacing: 0px; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.</p> | |
| CY2017Q3 | apyp |
Working Capital Deficit
WorkingCapitalDeficit
|
-575925 | usd |
| CY2017Q2 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
250877 | usd |
| CY2017Q3 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
193846 | usd |
| CY2017Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
11267 | usd |
| CY2017Q3 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
17657 | usd |
| CY2017Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
87240 | usd |
| CY2017Q3 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
72927 | usd |
| CY2017Q2 | us-gaap |
Convertible Debt
ConvertibleDebt
|
174904 | usd |
| CY2017Q3 | us-gaap |
Convertible Debt
ConvertibleDebt
|
138576 | usd |
| CY2017Q2 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
0 | usd |
| CY2017Q3 | us-gaap |
Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
|
0 | usd |
| CY2017 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0.00 | pure |
| CY2017Q3 | apyp |
Addition Of New Derivatives Recognized As Debt Discounts
AdditionOfNewDerivativesRecognizedAsDebtDiscounts
|
67500 | usd |
| CY2017Q3 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
-88294 | usd |
| CY2013Q1 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
200 | usd |
| CY2016Q3 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
607 | usd |
| CY2017Q3 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
613 | usd |
| CY2013Q1 | us-gaap |
Lessor Leasing Arrangements Operating Leases Term Of Contract
LessorLeasingArrangementsOperatingLeasesTermOfContract
|
P3M | |
| CY2013Q1 | us-gaap |
Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
|
three-month terms, which shall be automatically extended for successive three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term. | |
| CY2017Q3 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
1500 | shares |
| CY2017Q3 | us-gaap |
Preferred Stock Voting Rights
PreferredStockVotingRights
|
voting rights of 1,000 shares of common stock | |
| CY2017Q2 | apyp |
Percentage Net Collected Revenue Paid To Recruited Customers
PercentageNetCollectedRevenuePaidToRecruitedCustomers
|
0.35 | pure |
| CY2017Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
5993 | usd |
| CY2017Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
99256 | usd |
| CY2017Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
200 | usd |
| CY2017Q3 | us-gaap |
Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
|
-137170 | usd |
| CY2017Q3 | apyp |
Addition Of New Derivatives Recognized As Loss On Derivatives
AdditionOfNewDerivativesRecognizedAsLossOnDerivatives
|
222531 | usd |
| CY2016Q3 | us-gaap |
Litigation Settlement Expense
LitigationSettlementExpense
|
67500 | usd |
| CY2017Q3 | us-gaap |
Litigation Reserve
LitigationReserve
|
67500 | usd |
| CY2017Q3 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
175131324 | shares |
| CY2017Q3 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
69284 | usd |
| CY2017Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
30000000 | shares |
| CY2017Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
200 | usd |
| CY2017Q3 | apyp |
Stock Issued Period For Common Stock Payable
StockIssuedPeriodForCommonStockPayable
|
57273 | usd |
| CY2017 | apyp |
Stock Payable For Service
StockPayableForService
|
105000 | usd |
| CY2017 | apyp |
Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
|
55000000 | shares |
